Table 1 Patients’ characteristics
Characteristic | No. | Â |
|---|---|---|
Age | ||
 Median (range) | 83 (56–89) |  |
Gender | ||
 Male | 19 | 59.4% |
 Female | 13 | 40.6% |
Histology | ||
 Adenocarcinoma | 24 | 75.0% |
 Squamous cell carcinoma | 7 | 21.9% |
 Non-small cell carcinoma | 1 | 3.1% |
Morphology | ||
 Solid/part solid | 26 | 81.3% |
 GGO | 6 | 18.8% |
Stage | Â | Â |
 I | 23 | 71.9% |
 II | 9 | 28.1% |
Prescription dose: | ||
 40 Gy/4 fr (PTV D95) | 23 | 71.9% |
 48 Gy/4 fr (isocenter) | 9 | 28.1% |
Prognosis | ||
 Non-recurrent | 23 | 71.9% |
 Recurrent | 9 | 28.1% |